REGINfo: Sanofi-Aventis - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

COMPANY SEARCH RESULT

$Sanofi-Aventis: Click to view the issuer\'s details$

Last update : 29/03/2019 >View issuer details

2020.01.17 | 18:00 | Share History / Voting Rights and Number of Shares

puce Sanofi: information concerning the total number of voting rights and shares, December 2019 - HTML (w)

2020.01.17 | 18:00 | Share History / Voting Rights and Number of Shares

puce Sanofi : informations relatives au nombre total de droits de vote et d’actions, décembre 2019 - HTML (w)

2020.01.14 | 18:00 | Share Buybacks / Share redemption disclosures

puce Sanofi: Disclosure of trading in own shares - HTML (w)

2020.01.14 | 18:00 | Share Buybacks / Share redemption disclosures

puce Sanofi : Déclaration des transactions sur actions propres - HTML (w)

2020.01.09 | 19:01 | Share Buybacks / Share redemption disclosures

puce Sanofi: Disclosure of trading in own shares - HTML (w)

2020.01.09 | 19:01 | Share Buybacks / Share redemption disclosures

puce Sanofi : Déclaration des transactions sur actions propres - HTML (w)

2020.01.09 | 07:30 | Permanent Information Releases / Notification of availability

puce Sanofi : Availability of the Pre-quarterly Results Communication - HTML (w)

2020.01.09 | 07:30 | Permanent Information Releases / Notification of availability

puce Sanofi : Mise en ligne du document «Pre-quarterly Results Communication » - HTML (w)

2019.12.23 | 12:08 | Share History / Voting Rights and Number of Shares

puce Sanofi: information concerning the total number of voting rights and shares, November 2019 - HTML (w)

2019.12.23 | 12:08 | Share History / Voting Rights and Number of Shares

puce Sanofi : informations relatives au nombre total de droits de vote et d’actions, novembre 2019 - HTML (w)

2019.12.23 | 07:00 | Public offerings / Press Releases during Offer Period

puce Sanofi commences tender offer for acquisition of Synthorx, Inc. - HTML (w)

2019.12.23 | 07:00 | Public offerings / Press Releases during Offer Period

puce Sanofi lance l’offre publique d’achat en vue de l’acquisition de Synthorx, Inc. - HTML (w)

2019.12.10 | 14:30 | Permanent Information Releases / General Company News

puce Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab) - HTML (w)

2019.12.10 | 14:30 | Permanent Information Releases / General Company News

puce Sanofi et Regeneron annoncent leur intention de restructurer leur accord de collaboration sur les anticorps concernant Kevzara® (sarilumab) et Praluent® (alirocumab) - HTML (w)

2019.12.10 | 13:30 | Permanent Information Releases / General Company News

puce Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2767